Stay updated on Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.

Latest updates to the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page
- Check7 days agoChange DetectedA dedicated Locations section is added with Connecticut listed as a site, and the previous Connecticut Locations entry plus the HHS Vulnerability Disclosure link are removed.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows Revision: v3.3.2 replacing v3.2.0; this is a minor update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe banner about government funding/NIH operating status is no longer displayed on the page.SummaryDifference0.4%

- Check57 days agoChange DetectedNo significant changes detected between the old and new screenshots of the Study Details page for NCT02407171; the page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check86 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check93 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.